NEPH vs RUN · P/E 48, rev $14.2M vs P/E 6.0, rev $2.04B
Nephros Inc (NEPH) versus Sunrun Inc (RUN) — a side-by-side from cached financials, not a winner call.
Nephros Inc (NEPH) is a medical instruments & supplies company listed on US.
Sunrun Inc (RUN) is a solar company listed on NASDAQ.
Latest reported NEPH revenue for 2024-12-31 was $14.2M. Net income was $74.0K. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. NEPH currently screens at market cap $40.9M and trailing P/E 48.3.
Latest reported RUN revenue for 2024-12-31 was $2.04B. Net income was -$4.36B. Revenue was down 9.8% from 2023-12-31 to 2024-12-31. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
NEPH currently screens at market cap $40.9M and trailing P/E 48.3. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
Not investment advice. Open the NEPH and RUN stock pages for the full models.
Not investment advice.